Abstract: A flexible printed circuit board includes a main flexible board and a bridging flexible board, wherein the main flexible board includes a first main pad, a second main pad, a first signal line and a second signal line, and the bridging flexible board includes a first bridging pad and a second bridging pad; the first main pad includes at least two first solder joints, the second main pad includes at least two second solder joints, the first bridging pad includes at least two third solder joints, and the second bridging pad includes at least two fourth solder joints.

Abstract: The disclosure provides a control method and a device for an air conditioner. The method includes: a first reward matrix is constructed according to multiple sets of target operating parameters of an air conditioner, a maximum expected benefit of performing a current action in a current state is calculated based on the first reward matrix and a Q-learning algorithm, wherein the current state is represented by a current indoor environment temperature and a current outdoor environment temperature; target action parameters under the maximum expected benefit are acquired, and operation of the air conditioner is controlled based on second target action parameters, wherein the second target action parameters at least include a second target operating frequency of the compressor, a second target opening degree of the electronic expansion valve and a second target rotating speed of the external fan.

Abstract: The present application provides a precise ion implantation type modified geopolymer and an efficient preparation method thereof, wherein the precise ion implantation type modified geopolymer comprise: a geopolymer source material with a specific size, which implanted by Si and Al ions with a designated dose by an ion implanter. The geopolymer source material consists of a mixture of solid waste, alkali activator, and water.

Abstract: A connector assembly comprises a connector and a temperature sensor. The connector includes a connector housing formed with a sensor slot, and a conductive terminal arranged in the connector housing. The temperature sensor is inserted into the sensor slot and is adapted to detect a temperature of the conductive terminal in the connector. The sensor includes a shell having a first sidewall in thermal contact with the conductive terminal, and a second sidewall opposite to the first sidewall. The second sidewall defines an interference fit portion extending from an outer surface thereof. The interference fit portion forms an interference fit with an inner wall of the sensor slot. A remaining portion of the second sidewall except for the interference fit portion is separated from the inner wall of the sensor slot by a predetermined gap. The sensor further includes a temperature sensing element arranged in the shell.

Abstract: The present invention provides a compound of Formula (I) and pharmaceutical compositions comprising one or more said compounds, and methods for using said compounds for treating or preventing one or more disease states that could benefit from inhibition of plasma kallikrein, including hereditary angioedema, uveitis, posterior uveitis, wet age related macular edema, diabetic macular edema, diabetic retinopathy and retinal vein occlusion. The compounds are selective inhibitors of plasma kallikrein.

Abstract: A method for generating a brush effect picture includes: determining a pattern extraction area on a display interface in response to an area selection operation on the display interface of a display; obtaining a first brush effect picture based on the pattern extraction area, where a pattern of the first brush effect picture is a pattern corresponding to the pattern extraction area on the display interface; and obtaining a second brush effect picture based on the first brush effect picture, where the pattern of the first brush effect picture is the same as a pattern of the second brush effect picture, and definition of the second brush effect picture is greater than definition of the first brush effect picture.

Abstract: The present invention is directed to macrocyclic urea compounds which are agonists of orexin receptors. The present invention is also directed to uses of the compounds described herein in the potential treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The present invention is also directed to compositions comprising these compounds. The present invention is also directed to uses of these compositions in the potential prevention or treatment of such diseases in which orexin receptors are involved.

Abstract: A controllable downhole drilling and completion tool separating device and their method of use are provided. The device includes an upper mandrel connector, an outer sleeve, a claw clamp sleeve, a claw clamp locking ring, a mandrel sleeve, a lower connector, a piston ring and a pressure bearing ball. The upper end of the lower connector is on the outer side of the upper connector in a sleeving mode. A first annular cavity is between the lower connector and the upper connector. The piston ring is on the outer side of the upper connector in a sleeving mode and located in the first annular cavity. The claw clamp sleeve and the outer sleeve are sequentially arranged on the outer side of the upper connector in a sleeving mode. A second annular cavity is communicated with the first annular cavity and formed between the claw clamp sleeve and the upper connector.

Abstract: The present invention provides compounds of the structural Formula (I) and pharmaceutically acceptable salts thereof, wherein, are as defined herein, pharmaceutical compositions comprising one or more such compounds (alone and in combination with one or more other therapeutically active agents), and methods for their preparation and use, alone and in combination with other therapeutic agents, as antagonists of A2a and/or A2b receptors, and in the treatment of a variety of diseases, conditions, or disorders that are mediated, at least in part, by the adenosine A2a receptor and/or the adenosine A2b receptor.

Abstract: Example comment adding methods and communication terminals are disclosed. One example comment adding method includes displaying, by an electronic device, in a first region, first content at a content layer. The electronic device receives a first operation of a finger and a second operation of a stylus within a first preset duration range. The electronic device loads a comment layer on the content layer in response to the first operation and the second operation. The electronic device receives, at the comment layer in response to a third operation of the stylus, a first comment input by the stylus for the first content. The electronic device displays, in the first region in response to the first comment, the first content including the first comment. The first region is any region that can be displayed on the display, and a display position of the first content in the first region remains unchanged.

Abstract: The present invention is directed to cyclopentapyrrole, furopyrrole and azabicycloheptane compounds which are agonists of orexin receptors. The present invention is also directed to uses of the compounds described herein in the potential treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The present invention is also directed to compositions comprising these compounds. The present invention is also directed to uses of these compositions in the potential prevention or treatment of such diseases in which orexin receptors are involved.

Abstract: A remote intelligent active drilling pressure control system and method. The system includes a drilling pump, a rotary blowout preventer, a ground simple throttle control manifold, a wellhead back pressure compensation manifold, a graded filling device, a downhole storage-type pressure measuring device, a ground multi-parameter online monitoring system, a drilling hydraulic calculation system, an MPD intelligent control platform and a remote monitoring and control system. The present invention provides a wellbore pressure control thought of “plugging and control integration”, improves the pressure resistance of a formation by circularly plugging while drilling, realizes active control of a wellbore pressure, effectively broadens a “drilling safety density window” of the formation, and reduces the requirements on the pressure control precision of a wellbore pressure control device.

Abstract: A modular multifunctional electronic smoking paraphernalia includes a main body module provided with a slide rod a and a slide rod b, a cigarette holder module provided with a slide groove a, and an atomization module provided with a slide groove b. The cigarette holder module is detachably and slidably connected to the main body module by the slide rod a and the slide groove a. The atomization module is detachably and slidably connected to the main body module by the slide rod b and the slide groove b. In the present invention, the smoking paraphernalia is designed as three detachable modules, namely, the main body module, the cigarette holder module and the atomization module, which is convenient for the smoker to operate.

Abstract: The invention provides for Compound I or a pharmaceutically acceptable salt thereof (I) for use in the prevention and/or treatment of an organ injury, or a condition associated with an organ injury, in a subject diagnosed with, or suffering from an infection.

Abstract: Provided herein is Compound I or a pharmaceutically acceptable salt thereof for use in the prevention and/or treatment of a kidney condition or disease in a subject exposed to a nephrotoxin capable of inducing said kidney condition or disease.

Abstract: The present invention provides a compound of Formula (I) and pharmaceutical compositions comprising one or more said compounds, and methods for using said compounds for treating or preventing thromboses, embolisms, hypercoagulability or fibrotic changes. The compounds are selective Factor XI activation inhibitors.

Abstract: Disclosed are an IC card asymmetric labelling system, an IC card built-in password input system and an IC card built-in password input method. The IC card asymmetric labelling system includes: an IC card, a payment terminal and a cloud end sever. The IC card includes a crypto-key unit and a communication module. The crypto-key unit stores a first private key which is used to sign a message transmitted from the IC card. The communication module establishes a communication connection with a cloud end through the payment terminal, or directly establishes a communication connection with the cloud end. The cloud end stores an open ID of the IC card and associated user information. The open ID is a hash value of a first public key of the IC card and is open to the public.

Abstract: The present invention relates to pegylated amino acid compounds of Formula I: and pharmaceutically acceptable salts thereof, wherein X, R1, R2, R3A, R3B and n are as defined herein. The present invention also relates to compositions which comprise a pegylated amino acid compound of the invention or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier, in combination with a high concentration of an active biological ingredient (ABI). In embodiments of the invention, the ABI is an anti-PD-1 antibody or antigen binding fragment thereof that specifically binds human programmed death receptor 1 (PD-1). The invention further relates to methods for lowering the viscosity of an aqueous solution of a pharmaceutical composition comprising adding a compound of the invention to the solution.

Abstract: Disclosed herein are compounds of formula (I) which are inhibitors of an IDO enzyme: (I). Also disclosed herein are uses of the compounds in the potential treatment or prevention of an IDO-associated disease or disorder. Also disclosed herein are compositions comprising these compounds. Further disclosed herein are uses of the compositions in the potential treatment or prevention of an IDO-associated disease or disorder.

Abstract: Transactions between account-based endpoints are performed in a two-step process that first qualifies the recipient's validity and then performs the actionable transfer. The qualification step, unlike a payment pre-qualification, validates the recipient account validity while collecting information required for filling out a transaction data set. The information may include anti-money laundering and know-your-customer information as well as specific account details needed for on-boarding. A recipient payouts service provider may be assigned a tokenized bank identification number for use in routing the transfer through existing financial processing networks. Data constructs, minimum required information, and format checks may be facilitated by initiator-side and recipient-side application program interfaces.